A Randomized, Double-Blind, Placebo-Controlled, Phase 1, Multiple-Ascending Dose Study of MS-553 in Healthy Volunteers

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled, Phase 1, Multiple-Ascending Dose Study of MS-553 in Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 19 Mar 2016

At a glance

  • Drugs MS 553 (Primary)
  • Indications Diabetic retinopathy
  • Focus Adverse reactions
  • Sponsors MingSight Pharmaceuticals
  • Most Recent Events

    • 14 Mar 2016 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
    • 10 Jun 2015 Status changed from not yet recruiting to recruiting, as per ClinicalTrials.gov record.
    • 07 Apr 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top